全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

查看量下载量

相关文章

更多...
PLOS ONE  2014 

The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania

DOI: 10.1371/journal.pone.0084824

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background Insufficient access to essential medicines is a major health challenge in developing countries. Despite the importance of Standard Treatment Guidelines and National Essential Medicine Lists in facilitating access to medicines, little is known about how they are updated. This study aims to describe the process of updating the Standard Treatment Guidelines and National Essential Medicine List in Tanzania and further examines the criteria and the underlying evidence used in decision-making. Methods This is a qualitative study in which data were collected by in-depth interviews and document reviews. Interviews were conducted with 18 key informants who were involved in updating the Standard Treatment Guidelines and National Essential Medicine List. We used a thematic content approach to analyse the data. Findings The Standard Treatment Guidelines and National Essential Medicine List was updated by committees of experts who were recruited mostly from referral hospitals and the Ministry of Health and Social Welfare. Efficacy, safety, availability and affordability were the most frequently utilised criteria in decision-making, although these were largely based on experience rather than evidence. In addition, recommendations from international guidelines and medicine promotions also influenced decision-making. Cost-effectiveness, despite being an important criterion for formulary decisions, was not utilised. Conclusions Recent decisions about the selection of essential medicines in Tanzania were made by committees of experts who largely used experience and discretionary judgement, leaving evidence with only a limited role in decision-making process. There may be several reasons for the current limited use of evidence in decision-making, but one hypothesis that remains to be explored is whether training experts in evidence-based decision-making would lead to a better and more explicit use of evidence.

 References

[1]  WHO (2004) Equitable access to essential medicines: a framework for collective action. Geneva: World Health Organization.
[2]  Cameron A, Roubos I, Ewen M, Mantel-Teeuwisse AK, Leufkens HGM, et al. (2011) Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organ 89: 412–421.
[3]  Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R (2009) Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 373: 240–249.
[4]  WHO (2011) The world medicine situation. Geneva, Switzerland: World Health Organization.
[5]  United Nations (2008) The Millennium Development Goals Report (MDG Goal 8E). New York.
[6]  WHO (2008) The world health report 2008: primary health care now more than ever. Geneva: World Health Organization.
[7]  WHO (2003) The selection and use of essential medicines. Technical Report Series No 914: 15 Geneva: World Health Organization.
[8]  Holloway C, Green T, Carandang E, Hogerzeil H, Laing R, et al.. (2003) Managing the formulary process. In: Holloway C, editor. Drugs and Therapeutic Committees: A Practical Guide. Geneva: World Health Organization.
[9]  Laing RO, Hogerzeil HV, Ross-Degnan D (2001) Ten recommendations to improve use of medicines in developing countries. Health Policy Plan 16: 13–20.
[10]  Kafuko J, Bagenda D (1994) Impact of national standard treatment guidelines on rational drug use in Uganda health facilities. Unicef: Kampala,Uganda.
[11]  Hogerzeil HV (2004) The concept of essential medicines: lessons for rich countries. BMJ 329: 1169–1171.
[12]  Quick JD (2003) Essential medicines twenty-five years on: closing the access gap Health Policy Plan. 18: 1–3.
[13]  WHO (2002) Report of the WHO Expert Committee on the Selection and Use of Essential Medicines Geneva: World Health Organization.
[14]  Laing R, Waning B, Gray A, Ford N, ‘t Hoen E (2003) 25 years of the WHO essential medicines lists: progress and challenges. Lancet 361: 1723–1729.
[15]  Quick JD, Hogerzeil HV, Velá squez G, Rago L (2002) Twenty-five years of essential medicines. Bull World Health Organ 80: 913–914.
[16]  WHO (1977) The selection of essential drugs: report of a WHO expert committee. (Technical Report Series WHO no 615). World Health Organization, Geneva.
[17]  WHO UNESCO (1978) Primary health care: Report of the International Conference on Primary Health Care Geneva: World Health Organization.
[18]  Ministry of Health (1990) The National Health Policy. Dar es Salaam.
[19]  Ministry of Health (1991) Standard Treatment Guidelines and the National Essential Drug List for Tanzania 1st ed. Dar es Salaam: The Government Press.
[20]  Ministry of Health and Social Welfare (2011) Tanzania Mainland National Health Accounts 2009/10. Dar es Salaam.pp 20.
[21]  Department of Policy and Planning, Ministry of Health and Social Welfare (2013) Health Sector Performance Profile Report 2011. Dar es Salaam. 55.
[22]  Department of Policy and Planning, Ministry of Health (2008) Annual Health Statistical Abstract: Mainland Tanzania. Dar es Salaam.
[23]  Euro Health Group (2007) Drug Tracking Study Royal Danish Embassy, Dar es Salaam-Tanzania.
[24]  National Bureau of Statistics (2013) 2012 Population Housing Census. Dar es Salaam, United Republic of Tanzania.
[25]  National Bureau of Statistics, ICF Macro (2011) Tanzania Demographic and Health Survey: 2010. Dar es Salaam, Tanzania.
[26]  NICE (2008) Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence.
[27]  CADTH (2006) Guidelines for the economic evaluation of health technologies. : Canadian Agency for Drugs and Technologies in Health: Ottawa, Canada.
[28]  WHO (2002) WHO Policy Perspective on Medicines: The Selection of Essential Medicines. Geneva: World Health Organization.
[29]  Yin RK (2003) Case study research: Design and methods. Thousand Oaks, CA: Sage.
[30]  Baxter P, Jack S (2008) Qualitative Case Study Methodology: Study Design and Implementation for Novice Researchers. The Qualitative Report 13: 544–559.
[31]  Sandelowski M (2000) Focus on Research Methods Whatever Happened to Qualitative Description? Res Nurs Health 23: 334–340.
[32]  Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREC): a 32-item checklist for interviews and focus groups. Int J Quality Car 19: 349–357.
[33]  Mori AT, Robberstad B (2012) Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review BMC Med Inform Decis Mak. 12: 110 doi:10.1186/1472-6947-12-110.
[34]  McLellan E, MacQueen KM, Niedig JL (2003) Beyond the qualitative interview: Data preparation and transcription. Field Methods 15: 63–84.
[35]  Green J, Thorogood N (2009) Qualitative Methods for Health Research. London: Sage Publications Ltd.
[36]  CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A, Brohi K, et al (2011) The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 377: 1096–1101.
[37]  Robertson J, Hill SR (2007) The Essential Medicines List for a Global Patient Population. Clin Pharmacol Ther 82: 498–500.
[38]  WHO (2012) The Selection and Use of Essential Medicines: Report of the WHO Expert Committee, 2011. Geneva: World Health Organization.
[39]  Orem JN, Wavamunno JB, Bakeera SK, Criel B (2011) Do guidelines influence the implementation of health programs? – Uganda’s experience. Implement Sci 7: doi:10.1186/1748-5908-1187-1198.
[40]  Holly AN, Durrheim D, Rima S (2003) The process of changing national malaria treatment policy: lessons from country-level studies. Health Policy Plan 19: 356–370.
[41]  Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, et al. (2007) The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J 6: 72 doi:10.1186/1475-2875-6-72.
[42]  Mori AT, Kaale EA (2012) Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: Evaluation against the accountability for reasonableness framework. Implement Sci 7: 18 doi:10.1186/1748-5908-7-18.
[43]  Nanyunja M, Orem JN, Kato F, Kaggwa M, Katureebe C, et al.. (2011) Malaria Treatment Policy Change and Implementation: The Case of Uganda. Malar Res Treat: doi:10.4061/2011/683167.
[44]  Ellen ME, Leon G, Bouchard G, Lavis JN, Ouimet M, et al. (2013) What supports do health system organizations have in place to facilitate evidence-informed decision-making? a qualitative study. Implement Sci 8: 84 doi:10.1186/1748-5908-8-84.
[45]  Anell A (2004) Priority setting for pharmaceuticals; The use of health economic evidence by reimbursement and clinical guidance committees. Eur J Health Econ 5: 28–35.
[46]  Odedina F, Sullivan J, Nash R, Clemmons C (2002) Use of pharmacoeconomic data in making hospital formulary decisions. Am J Health Syst Pharm 59: 1441–1444.
[47]  Chen LC, Ashcroft DM, Elliott RA (2007) Do economic evaluations have a role in decision-making in Medicine Management Committees? A qualitative study. Pharm World Sci 29: 661e670.
[48]  Sp？th HM, Charavel M, Morelle M, Odile Carrere M (2003) A qualitative approach to the use of economic data in the selection of medicines for hospital formularies: a French survey. Pharm World Sci 25: 269–275.
[49]  Mori AT, Gavaza P, Robberstad B (2013) The role of Pharmacoeconomics in developing countries. Farmeconomia Health economics and therapeutic pathways 14: 3–5.
[50]  Robberstad B, Hemed Y (2010) Economic Evaluations of Health Interventions: Tanzania Perspectives. Springer Science+Business Media LLC: 548–586.
[51]  Britten N (1995) Qualitative interviews in medical research. In: Mays N, Pope C, editors. Qualitative Research in Health Care. London: BMJ Publishing Group. 28–35.
[52]  Strauss A, Corbin J (1990) Basics of qualitative research: Grounded theory procedures and techniques. Newbury Park CA: Sage.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133